4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-19-050493
Chief Executive Officer bought 2,000 shares at $5.25 ($10,500)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Plavan Matthew T Chief Executive Officer | 2019-09-23 | Purchase | +2,000 | $5.25 | $10,500 | 12,000 | D: show line 1 in the form |
| Open-market purchases · 2,000 sh · avg $5.25 · $10,500 | |||||||
Loading xslF345X03/doc4.xml…